Reprint

New Advances in Kidney Transplantation

Edited by
November 2022
178 pages
  • ISBN978-3-0365-5753-3 (Hardback)
  • ISBN978-3-0365-5754-0 (PDF)

This book is a reprint of the Special Issue New Advances in Kidney Transplantation that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

This Special Issue in renal transplantation covers a variety of clinical and research areas in kidney transplantation. The recent decade is associated with an ongoing shortage of organs for transplantation with efforts to increase the organ pool with DCDs and extended criteria donors. However, with the increasing success rate of kidney transplants, there is also a growth in the candidate list because of removal of the age barrier and transplantation of high risk patients with other comorbidities. The future seems promising with the development of innovative non-invasive technologies introducing biomarkers for diagnosis of rejection and ischemic reperfusion injury, use of cell therapy for tolerance induction, development of artificial organs, and overcoming immune and non-immune barriers in xenotransplantation. This Special Issue will touch some of these topics that are in the frontiers of the modern era of kidney transplantation.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
kidney allograft; neutrophil gelatinase-associated lipocalin; matrix metalloproteinase 9-neutrophil gelatinase-associated lipocalin complex; glomerular filtration rate; urinary tract infections; plasmapheresis; kidney transplantation; desensitization; donor specific antibody; uromodulin; Tamm-Horsfall-protein; kidney transplantation; delayed graft function; ischemia-reperfusion injury; clinical research practice; near-infrared spectroscopy; kidney transplantation; initial allograft function; intraoperative; tissue oxygen saturation; dialysis; elderly; expanded criteria donor; kidney transplantation; BMI; ethnicity; living donation; kidney transplant; recipient’s demographics; cumulative incidence; everolimus; de novo cancer; kidney transplantation; mammalian target of rapamycin; survival; kidney transplantation; graft quality assessment; biomarkers; machine perfusion; IRI; DGF; peritoneal dialysis; hemodialysis; kidney transplantation; autoimmunity; kidney; metanephros; organogenesis; transplantation; regenerative medicine; n/a